Beam Therapeutics Inc.

BEAM Healthcare
$26.76 $-0.07 (-0.26%)
Market Cap: $2.64 B
Gurus Holding
3
Popularity Rank
#2547
% of Shares Held
11.21%
Net Activity (Q3 2025)
+$52.27 M

Guru Ownership Trend

Guru Analysis for Beam Therapeutics Inc. (BEAM)

Beam Therapeutics Inc. (BEAM), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q3 2025, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $295.96 M.

Top institutional holders include Catherine Wood and Cliff Asness.

Institutional sentiment is currently Strongly Bullish. This is evidenced by a $52.27 M net inflow during the quarter.

Recent activity highlights Murray Stahl who opened a new position. Conversely, Cliff Asness reduced exposure by 55.8%.

Portfolio Manager % Portfolio Activity Shares Value Period
1.59% Add 24.8% 11,038,834 $267.91 M Q3 2025
0.00% Reduce -55.8% 11,226 $272,455 Q3 2025
0.00% New Buy 9,597 $232,919 Q3 2025

Key Holders

Top 5 by Value

$267.91 M
$272,455
$232,919

Top 5 by Conviction

Recent Activity Breakdown (Q3 2025)

+$53.41 M
Total Buy Value
New Buys 1
Additions 1
-$1.13 M
Total Sell Value
Reductions 1
Sold Out 1

Guru Consensus (Q3 2025)

Based on recent activity
Net Sellers
2
Net Buyers
2

FAQs for Beam Therapeutics Inc. (BEAM)

Top Guru holders include Catherine Wood ($267.91 M), Cliff Asness ($272,455), Murray Stahl ($232,919). Collectively, tracked Gurus hold 11.06 M shares.

Based on recent 13F filings, the sentiment is Positive (Net Buy). There was a net inflow of $52.27 M, with 2 Gurus buying and 2 Gurus selling.

In the recent quarter, 1 Gurus reduced their positions, and 1 Gurus sold out of BEAM completely. Total sell value was $1.13 M.

Yes, 1 Gurus opened new positions in BEAM, and 1 added to their existing holdings. Total buy value was $53.41 M.